Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,275,345 papers from all fields of science
Search
Sign In
Create Free Account
solid tumor
Known as:
solid tumors
, solid tumour
, Solid tumor, NOS
Expand
A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
ERBB3 gene
ERBB3 wt Allele
ERBB4 gene
ERBB4 wt Allele
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
D. Le
,
D. Le
,
+55 authors
L. A. Diaz
Science
2017
Corpus ID: 206661248
Predicting responses to immunotherapy Colon cancers with loss-of-function mutations in the mismatch repair (MMR) pathway have…
Expand
Review
2010
Review
2010
Delivering nanomedicine to solid tumors
R. Jain
,
T. Stylianopoulos
Nature Reviews Clinical Oncology
2010
Corpus ID: 18093524
Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. While the enhanced…
Expand
Review
2009
Review
2009
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
R. Wahl
,
H. Jacene
,
Y. Kasamon
,
M. Lodge
Journal of Nuclear Medicine
2009
Corpus ID: 15656065
The purpose of this article is to review the status and limitations of anatomic tumor response metrics including the World Health…
Expand
Highly Cited
2009
Highly Cited
2009
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
J. Wolchok
,
A. Hoos
,
+9 authors
Stephen F. Hodi
Clinical Cancer Research
2009
Corpus ID: 10182411
Purpose: Immunotherapeutic agents produce antitumor effects by inducing cancer-specific immune responses or by modifying native…
Expand
Review
2007
Review
2007
Drug resistance and the solid tumor microenvironment.
O. Trédan
,
C. Galmarini
,
Krupa J. Patel
,
I. Tannock
Journal of the National Cancer Institute
2007
Corpus ID: 41588033
Resistance of human tumors to anticancer drugs is most often ascribed to gene mutations, gene amplification, or epigenetic…
Expand
Highly Cited
2006
Highly Cited
2006
A microRNA expression signature of human solid tumors defines cancer gene targets
S. Volinia
,
G. Calin
,
+15 authors
C. Croce
Proceedings of the National Academy of Sciences…
2006
Corpus ID: 13617838
Small noncoding microRNAs (miRNAs) can contribute to cancer development and progression and are differentially expressed in…
Expand
Highly Cited
2003
Highly Cited
2003
A molecular signature of metastasis in primary solid tumors
Sridhar Ramaswamy
,
K. Ross
,
E. Lander
,
T. Golub
Nature Genetics
2003
Corpus ID: 12059602
Metastasis is the principal event leading to death in individuals with cancer, yet its molecular basis is poorly understood. To…
Expand
Review
2000
Review
2000
New guidelines to evaluate the response to treatment in solid tumors
P. Therasse
,
S. Arbuck
,
+8 authors
S. Gwyther
Journal of the National Cancer Institute
2000
Corpus ID: 31905278
Anticancer cytotoxic agents go through a process by which their antitumor activity-on the basis of the amount of tumor shrinkage…
Expand
Review
2000
Review
2000
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda
,
J. Wu
,
T. Sawa
,
Y. Matsumura
,
K. Hori
Journal of Controlled Release
2000
Corpus ID: 3895278
Review
2000
Review
2000
[New guidelines to evaluate the response to treatment in solid tumors].
F. Duffaud
,
P. Therasse
Bulletin du Cancer
2000
Corpus ID: 15541119
Anticancer agents go through a process by which their antitumor activity, on the basis of the amount of tumor shrinkage they…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required